Nakamura, A.;                     Suzuki, S.;                     Kanasugi, J.;                     Ejiri, M.;                     Hanamura, I.;                     Ueda, R.;                     Seto, M.;                     Takami, A.    
        Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma. Int. J. Mol. Sci. 2021, 22, 10761.
    https://doi.org/10.3390/ijms221910761
    AMA Style
    
                                Nakamura A,                                 Suzuki S,                                 Kanasugi J,                                 Ejiri M,                                 Hanamura I,                                 Ueda R,                                 Seto M,                                 Takami A.        
                Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma. International Journal of Molecular Sciences. 2021; 22(19):10761.
        https://doi.org/10.3390/ijms221910761
    
    Chicago/Turabian Style
    
                                Nakamura, Ayano,                                 Susumu Suzuki,                                 Jo Kanasugi,                                 Masayuki Ejiri,                                 Ichiro Hanamura,                                 Ryuzo Ueda,                                 Masao Seto,                                 and Akiyoshi Takami.        
                2021. "Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma" International Journal of Molecular Sciences 22, no. 19: 10761.
        https://doi.org/10.3390/ijms221910761
    
    APA Style
    
                                Nakamura, A.,                                 Suzuki, S.,                                 Kanasugi, J.,                                 Ejiri, M.,                                 Hanamura, I.,                                 Ueda, R.,                                 Seto, M.,                                 & Takami, A.        
        
        (2021). Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma. International Journal of Molecular Sciences, 22(19), 10761.
        https://doi.org/10.3390/ijms221910761